Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by McKenna Mark C., Chief Executive Officer. Insider active across 5 companies, notably Prometheus Biosciences, Inc.. Aggregated, 13 filings have been recorded. Split: 1 buy · 0 sell. Total volume traded: €350k. Activity tracked since 1 December 2021. The latest transaction was disclosed on 12 December 2024 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to McKenna Mark C.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15,400 shares@ US$2.906.9% of flowCommon StockSEC:0001209191-21-067992:0
13 of 13 declarations
About McKenna Mark C.
McKenna Mark C. is Directeur Général and has reported 13 filings in total. Across the 13 sampled filings, the activity is mainly an option exercise, with purchases totaling EUR 349915, between 2021-12-03 and 2026-07-22, notably at Apogee Therapeutics, Inc. and Prometheus Biosciences, Inc.